![Christopher Cain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Cain
Director/Board Member at
COGENT BIOSCIENCES, INC.
Net worth: - $ as of 2026-05-30
Profile
Dr. Christopher Cain is an Independent Director at Damora Therapeutics, Inc., an Independent Director at Jade Biosciences, Inc., an Independent Director at Viridian Therapeutics, Inc. and an Independent Director at Cogent Biosciences, Inc. He is on the Board of Directors at Damora Therapeutics, Inc., Jade Biosciences, Inc., Viridian Therapeutics, Inc., Jade Biosciences, Inc. (United States) and Cogent Biosciences, Inc. Dr. Cain was previously employed as a Vice President by Samsara BioCapital LP and a Senior Associate by Apple Tree Venture Management Llc//vc.
He received his undergraduate degree from the University of California, Santa Barbara and a doctorate degree from The University of California, San Francisco.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-08 | 0 ( -.--% ) | - $ | 2026-05-30 | |
| 2026-06-30 | 0 ( -.--% ) | - $ | 2026-05-30 |
Christopher Cain active positions
| Companies | Position | Start |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Director/Board Member | 2020-07-05 |
| VIRIDIAN THERAPEUTICS, INC. | Director/Board Member | 2025-03-09 |
| JADE BIOSCIENCES, INC. | Director/Board Member | 2025-04-27 |
| DAMORA THERAPEUTICS, INC. | Director/Board Member | 2025-11-09 |
Former positions of Christopher Cain
| Companies | Position | End |
|---|---|---|
Samsara BioCapital LP
 Samsara BioCapital LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 2020-01-31 |
Apple Tree Venture Management Llc//vc
 Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Private Equity Analyst | 2019-02-27 |
Training of Christopher Cain
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
82
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apple Tree Venture Management Llc//vc
Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Finance |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Samsara BioCapital LP
Samsara BioCapital LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
- Stock Market
- Insiders
- Christopher Cain
Choose MarketScreener 
